Systems and methods for gene modification
The present disclosure provides a method for designing a set of guide RNAs for hybridizing a genomic region of interest. The present disclosure further provides methods of editing at least one genomic region of interest with at least one set of guide RNAs.
1. A system for modifying a gene within a cell, comprising:
(a) a first complex comprising a first gRNA and a first nuclease capable of generating double-stranded breaks;
(b) a second complex comprising a second gRNA and a second nuclease capable of generating double-stranded breaks; and
(c) a third complex comprising a third gRNA and a third nuclease capable of generating double-stranded breaks; wherein
(i) the first gRNA is configured to hybridize to a first genomic region of interest within the gene in the cell,
(ii) the second gRNA is configured to hybridize to a second genomic region of interest within the gene in the cell, and
(iii) the third guide RNA is configured to hybridize to a third genomic region of interest within the gene in the cell,
wherein the first gRNA, the second gRNA, and the third gRNA are each a different sequence, and wherein the first gRNA is configured to hybridize to a first binding site that is 30-80 base pairs apart from a second binding site hybridizable to the second gRNA and the second gRNA is configured to hybridize to the second binding site that is 30-80 base pairs apart from a third binding site hybridizable to the third gRNA to allow for modifying the gene with three double-stranded breaks;
wherein the first nuclease, the second nuclease, and the third nuclease each comprises a Cas9 nuclease, and
wherein the first complex, the second complex, and the third complex are provided in a single composition.
2. The system of claim 1 , further comprising a donor polynucleotide comprising a desired gene edit sequence, wherein when the cell is contacted with the donor polynucleotide, repair of the double-stranded breaks by a DNA repair process leads to integration of the desired gene edit sequence.
3. The system of claim 2 , wherein the desired gene edit sequence comprises a point mutation, an allele, a tag, or an exogenous exon relative to a wild-type genotype of the cell.
4. The system of claim 1 , further comprising another set of gRNAs configured to hybridize to another genomic region of interest, wherein the genomic region of interest and the another genomic region of interest are different.
5. The system of claim 1 , further comprising another set of gRNAs configured to hybridize to another genomic region of interest, wherein an another cell is contacted with the another set of gRNAs, and wherein the cell and the another cell are different, the set of gRNAs and the another set of gRNAs are different, and the genomic region of interest and the another genomic region of interest are different.
6. The system of claim 1 , wherein the first gRNA, the second gRNA, and the third gRNA comprise a 5′ end modification and a 3′ end modification, wherein the 5′ end modification comprises a phosphorothioate internucleotide linkage and a 2′-O-methyl sugar modification and the 3′ end modification comprises a phosphorothioate internucleotide linkage and a 2′-O-methyl sugar modification.
7. The system of claim 1 , wherein the modifying is a deletion.
8. The system of claim 1 , wherein the modifying is an indel.
9. The system of claim 1 , wherein the modifying is a knock-out.
10. The system of claim 9 , wherein the knock-out eliminates a function of the gene.
11. The system of claim 1 , wherein the first gRNA, the second gRNA, and the third gRNA are configured to hybridize to an exon in the gene.
12. The system of claim 11 , wherein the exon is a first exon of the gene.
13. The system of claim 1 , wherein the first gRNA, the second gRNA, or the third gRNA is configured to hybridize to a trans-regulatory unit.
14. The system of claim 1 , wherein the first gRNA, the second gRNA, or the third gRNA is configured to hybridize to a cis-regulatory unit.